Staphylococcus Lugdunensis Prosthetic Joint Infection
NCT04409392 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 84
Last updated 2021-06-16
Summary
Staphylococcus lugdunensis is a coagulase-negative staphylococcus belonging to the human commensal cutaneous flora, and has been little studied in the field of prosthetic joint infections. However, it shares many virulence traits with Staphylococcus aureus, including many adhesins and its ability to form biofilm, and the few series of cases reports a significant failure rate.
Conditions
- Staphylococcal Infections
- Prosthetic Joint Infection
Interventions
- OTHER
-
Prothestic joint infection due to Staphylococcus lugdunensis
description of prosthetic joint infection with Staphylococcus lugdunensis
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-01
- Primary Completion
- 2021-04-01
- Completion
- 2021-04-01
Countries
- France
Study Locations
More Related Trials
-
Bacterial Phenotype of Staphylococcus Aureus Has no Effect on Patients' Clinical Outcome in Orthopedic Device Related Bone Infections
NCT02971657 ·Status: COMPLETED
-
Daptomycin > 6 mg/kg/Day as Salvage Therapy in Patients With Complex Bone and Joint Infection: Cohort Study in a Regionalreference Center
NCT03209934 ·Status: COMPLETED
-
Clinical Evaluation of Daptomycin Bone Penetration
NCT01306825 ·Status: UNKNOWN
-
Evaluation of the Antibiofilmogramme® Test During Diabetic Foot Infections
NCT02378493 ·Status: COMPLETED ·Phase: NA
-
Biofilm Formation and Antibiotic Sensitivity Patterns
NCT05181163 ·Status: UNKNOWN
-
Antibiogram and Biofilm Formation of Bacteria Causing Prosthetic Joint Infections Isolated From Assiut University Hospital
NCT05239312 ·Status: UNKNOWN
-
Tedizolid Prolonged Treatment for Prosthetic Joint Infections
NCT03378427 ·Status: COMPLETED ·Phase: NA
-
Clindamycin in Prosthetic Joint Infections Caused by Staphylococcus (CISTA)
NCT04946500 ·Status: UNKNOWN
-
Evaluation of the Tolerance of Ceftaroline and Ceftobiprole in the Management of BJI / PJI
NCT04409769 ·Status: COMPLETED
-
Diagnostic and Management of Hand Infection.
NCT06630988 ·Status: ACTIVE_NOT_RECRUITING
-
Phage Safety Retrospective Cohort Study
NCT04724603 ·Status: RECRUITING
-
Staphylokinase and ABO Group Phenotype: New Players in Staphylococcus Aureus Implant-associated Infections Development
NCT02812446 ·Status: COMPLETED
-
Pathogenicity Factors of Staphylococcus Pettenkoferi in Foot Wounds and Osteitis in Diabetic Patients
NCT06688084 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of the Efficacy and Safety of Suppressive Therapy With DALBAVANCINE in Device Infections
NCT06089044 ·Status: COMPLETED
-
Linezolid-resistant Staphylococcus Epidermidis in ICU and Risk Factors Analysis
NCT03140410 ·Status: UNKNOWN
-
Daptomycin With Rifampin for Treatment of Staphylococcal Prosthetic Joint Infection
NCT01144000 ·Status: UNKNOWN ·Phase: PHASE2
-
Phage Therapy in Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR.
NCT05369104 ·Status: UNKNOWN ·Phase: PHASE2
-
Rifampin-combined Antibiotic Therapy for Staphylococcal PJI
NCT07313215 ·Status: RECRUITING ·Phase: NA
-
Microbiological Characteristics of Biofilm on Double J Ureteral Stents After Lithotripsy.
NCT07301294 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Subcutaneous Suppressive Antibiotic Therapy for Bone and Joint Infections
NCT03403608 ·Status: COMPLETED
-
Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci
NCT00428844 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Two Empirical Antimicrobial Therapies of Prosthetic Joint Infection
NCT03850860 ·Status: COMPLETED
-
Efficacy and Safety Study of Antibiotic Treatment to Treat Hip Prosthetic Joint Infection
NCT01757236 ·Status: UNKNOWN ·Phase: PHASE2
-
Clindamycin as Antimicrobial Treatment for Streptococcus Spp. PeRiprosthetic Infection
NCT07335627 ·Status: RECRUITING
-
The Personalised Antibiotic Duration for Cellulitis (PAD-C) Study
NCT05023200 ·Status: COMPLETED